Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: a response

Affiliations

Comment

Society for Maternal-Fetal Medicine, Publications Committee. Electronic address: pubs@smfm.org. Am J Obstet Gynecol. 2022 Jun.

. 2022 Jun;226(6):877.

doi: 10.1016/j.ajog.2022.01.016. Epub 2022 Jan 25.

¹ The Society for Maternal-Fetal Medicine, Publications Committee, 409 12 St., SW, Washington, DC 20024.

No abstract available

Comment on

Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, et al. Am J Obstet Gynecol. 2021 Nov;225(5):B36-B42. doi: 10.1016/j.ajog.2021.07.023. Epub 2021 Aug 5. Am J Obstet Gynecol. 2021. PMID: 34363784 Review.
SMFM Consult Series #58: Need for a clear evidence base to guide expanded use of antenatal corticosteroids for individuals at risk for late preterm delivery.
Vidaeff AC, Shamshirsaz AA, Aagaard KM. Vidaeff AC, et al. Am J Obstet Gynecol. 2022 Jun;226(6):876-877. doi: 10.1016/j.ajog.2022.01.015. Epub 2022 Jan 20. Am J Obstet Gynecol. 2022. PMID: 35065017 No abstract available.